FDA Inspection
Adamson Analytical Laboratories, Inc.Adamson Analytical Laboratories, Inc. – FDA Inspection, Oct 4, 2022
Record Details
This FDA Inspection record concerns Adamson Analytical Laboratories, Inc., with an inspection on October 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 41d5f351-cda4-4dfb-a422-de09de879fec
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1180976
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Adamson Analytical Laboratories, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2024 | VAI | Los Angeles District Office | Drug Quality Assurance |
| March 23, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Adamson Analytical Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.